Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
921
-
922
Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines.
Published 2021“…Only microexons with significant changes (q < 0.01, |ΔPSI| ≥ 5) are shown. Data underlying Fig 3A can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001138#pbio.3001138.s023" target="_blank">S3</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001138#pbio.3001138.s024" target="_blank">S4</a> Data. …”
-
923
-
924
-
925
-
926
(+)-Usnic acid decreases β-catenin-mediated TOPFLASH activity and KITENIN-mediated AP-1 activity.
Published 2016“…<p>(A) β-Catenin-mediated transcriptional activity of TOPFLASH promoter was decreased by (+)-usnic acid treatment. …”
-
927
Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend).
Published 2022“…<p>Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend).…”
-
928
-
929
-
930
-
931
-
932
-
933
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6
Published 2017“…GSK360A treatment significantly reduced post-stroke deficits in all tests (ANOVA group factor for all tests p < 0.01). …”
-
934
-
935
-
936
-
937
-
938
-
939
-
940